Interview with the magazine “Laborjournal”
Research and development without or with significantly less animal testing must be possible. We at Dynamic42 are convinced of this and at the same time on the way to realising this goal with the help of our organ-on-chip technology.
In an interview with the trade journal “Laborjournal”, our managing directors Martin Raasch and Knut Rennert explain how the Dynamic42 biotech chips work and how the “mini-organs” used contribute to reducing animal experiments.
The article also gives exciting insights into the background of our company and explains what our company name means.
Read the full interview in German: Laborjounal online: Nerdy names and runny noses
Recommendation: The magazine reported in more detail about our technology in the print edition. Laborjournal issue 03/22 (page 46/47)
Read more News:
Press Release | Dynamic42 develops new generation of biotech chips for organ-on-chip technology
BC003: The special feature of the new chip is the spatial design with three culture chambers. This enables the cultivation of complex, three-dimensional tissue cultures.Read More
Press Release | New organ-on-chip pilot seeks to reduce animal testing in consumer health industry
A first-of-its-kind collaboration in the consumer health industry is developing a platform aimed at reducing or replacing animal testing using “organ-on-chip” (OoC) technology and interactive computational software.Read More
Press Release | Dynamic42 Academy
Jena-based biotech company passes on expertise on future organ-on-chip technology to research institutions and companiesRead More